Enzem Pharmaceuticals Private Limited
About Enzem Pharmaceuticals Private Limited
Data last updated:
Enzem Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51101KA2014PTC075312. Its GSTIN is 29AADCE7082J1Z8 (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Kolakunte Satyanarayana Ramamurthy and Suma Ramamurthy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.35 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹2.59 Lakh (net margin 3.5%) and EBITDA of ₹5.38 Lakh (EBITDA margin 7.3%). Revenue has declined at a compounded annual rate (CAGR) of 1% over five years.
As per MCA filings, the company has open charges of ₹14 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address# 20 Mithila Ground Floor Phase I, Royal Elite Residency Cv Raman Road Kodipalya, Bangalore, Karnataka, India – 560060
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Enzem Pharmaceuticals Private Limited
The main business activity of Enzem Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Enzem Pharmaceuticals Private Limited FY 2025 filings available
Enzem Pharmaceuticals Private Limited reported revenue of ₹73.35 Lakh (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Enzem Pharmaceuticals Private Limited
Revenue rose 25% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Enzem Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.38 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.59 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Enzem Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Enzem Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Enzem Pharmaceuticals Private Limited
Enzem Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biotem Pharma Private Limited | ₹73.58 Lakh (FY 2025) | •••• | •••• | 29.0% | •••• | Bazpur, Uttarakhand, India |
| Riksan Pharmaceuticals Private Limited | ₹73.55 Lakh (FY 2025) | •••• | •••• | 25.0% | •••• | Mangalore, Karnataka, India |
| Corran Pharma Private Limited | ₹73.54 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Bassein, Maharashtra, India |
| Mayaan Pharmaceuticals Private Limited | ₹73.45 Lakh (FY 2024) | •••• | •••• | 76.0% | •••• | Hyderabad, Telangana, India |
| Sultan Pharmaceuticals Private Limited | ₹73.36 Lakh (FY 2023) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Enzem Pharmaceuticals Private Limited this company | ₹73.35 Lakh (FY 2025) | •••• | •••• | 25.0% | •••• | Bangalore, Karnataka, India |
| V.R. Medi Drugs Private Limited | ₹73.33 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Uttar Pradesh, India |
| Solisky Pharmaceuticals Private Limited | ₹73.32 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Ahmedabad, Gujarat, India |
| Ambromide Pharma Private Limited | ₹73.21 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Manimajra, Chandigarh, India |
| N Lexo Pharma Private Limited | ₹73.19 Lakh (FY 2024) | •••• | •••• | 383.0% | •••• | Gandhinagar, Gujarat, India |
| Kamla Amrut Life Care Private Limited | ₹73.19 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Sanand, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Enzem Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Enzem Pharmaceuticals Private Limited
Enzem Pharmaceuticals Private Limited is audited by SANTOSH KUMAR D AND CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANTOSH KUMAR D AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Enzem Pharmaceuticals Private Limited
Enzem Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kolakunte Satyanarayana Ramamurthy | Director | 10 Jul 2014 | 12 Years 3 Months | Current |
| Suma Ramamurthy | Director | 20 Feb 2018 | 8 Years 7 Months | Current |
Ownership and Shareholding of Enzem Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Enzem Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Feb 2020 | State Bank of India | ₹14 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Enzem Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Enzem Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Enzem Pharmaceuticals Private Limited
Enzem Pharmaceuticals Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Damodar Prabhu ceased to be Director on 17 Nov 2018.
Credit Ratings, Litigation & Regulatory Alerts for Enzem Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Enzem Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Enzem Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Enzem Pharmaceuticals Private Limited
Enzem Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCE7082J1Z8 | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Enzem Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enzem Pharmaceuticals Private Limited
Enzem Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 July 2014 (12+ years old) and is registered under CIN U51101KA2014PTC075312.
Enzem Pharmaceuticals reported revenue of ₹73.35 Lakh for FY 2025 (up 25% YoY).
Enzem Pharmaceuticals has 2 current directors:
- Kolakunte Satyanarayana Ramamurthy - Director
- Suma Ramamurthy - Director
Enzem Pharmaceuticals reported a net profit of ₹2.59 Lakh (net margin 3.5%) and EBITDA of ₹5.38 Lakh (EBITDA margin 7.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Enzem Pharmaceuticals is -1% over five years. In the latest year (FY 2025) revenue rose 25%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Enzem Pharmaceuticals is 29AADCE7082J1Z8, registered in Karnataka.
The CIN (Corporate Identification Number) of Enzem Pharmaceuticals is U51101KA2014PTC075312. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enzem Pharmaceuticals was incorporated on 10 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Enzem Pharmaceuticals by revenue are Biotem Pharma Private Limited, Riksan Pharmaceuticals Private Limited, Corran Pharma Private Limited, Mayaan Pharmaceuticals Private Limited, Sultan Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Damodar Prabhu ceased to be Director on 17 Nov 2018. Harshavardhana Ramachandrashastri Narashimarajpura ceased to be Director on 20 Feb 2018. Madhusudana Gururaja Rao ceased to be Director on 20 Feb 2018. Enzem Pharmaceuticals has 7 board changes on record in total.
The registered office of Enzem Pharmaceuticals is at # 20 Mithila Ground Floor Phase I, Royal Elite Residency Cv Raman Road Kodipalya, Bangalore, Karnataka, India – 560060.